DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
Primary Purpose
Rheumatic Heart Disease
Status
Completed
Phase
Not Applicable
Locations
Taiwan
Study Type
Interventional
Intervention
venipuncture to withdraw patient's blood
Sponsored by
About this trial
This is an interventional diagnostic trial for Rheumatic Heart Disease focused on measuring Rheumatic heart disease, HLA, Genetics, Taiwan
Eligibility Criteria
Inclusion Criteria: 1.Patients with Rheumatic mitral stenosis 2.Chinese Han ethnicity Exclusion Criteria: -
Sites / Locations
- Division of cardiology, China Medical University Hospital
Outcomes
Primary Outcome Measures
Secondary Outcome Measures
Full Information
NCT ID
NCT00264524
First Posted
December 12, 2005
Last Updated
November 26, 2010
Sponsor
China Medical University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT00264524
Brief Title
DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
Study Type
Interventional
2. Study Status
Record Verification Date
January 2004
Overall Recruitment Status
Completed
Study Start Date
January 2004 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
July 2005 (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
China Medical University Hospital
4. Oversight
5. Study Description
Brief Summary
The current study was designed to determine whether the HLA-DRB1, DQA1, DQB1 alleles are associated with the risk and the pattern of valve damage of RHD.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rheumatic Heart Disease
Keywords
Rheumatic heart disease, HLA, Genetics, Taiwan
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Masking
None (Open Label)
Allocation
Non-Randomized
8. Arms, Groups, and Interventions
Intervention Type
Procedure
Intervention Name(s)
venipuncture to withdraw patient's blood
10. Eligibility
Eligibility Criteria
Inclusion Criteria:
1.Patients with Rheumatic mitral stenosis 2.Chinese Han ethnicity
Exclusion Criteria:
-
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Hsiang-Tai Chou, MD, PhD
Organizational Affiliation
China Medical University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Division of cardiology, China Medical University Hospital
City
Taichung
ZIP/Postal Code
403
Country
Taiwan
12. IPD Sharing Statement
Learn more about this trial
DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
We'll reach out to this number within 24 hrs